Related Experiment Video
Updated: Jul 15, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
A 3D Bone Culture Platform Using Human Osteocytes and Decellularized Extracellular Matrix for Modeling
Francisco Verdugo-Avello1, Sebastián Carrasco2, Tomás Hermann3
1Facultad de Odontología, Universidad San Sebastián; Laboratorio de Biotecnología y Biofarmacia, Departamento de Fisiopatología, Facultad de Ciencias Biológicas, Universidad de Concepción; frverdugo@udec.cl.
Journal of Visualized Experiments : Jove
|July 13, 2026
Summary
Researchers developed a cost-effective 3D bone model using human osteocytes and decellularized extracellular matrix (dECM). This accessible platform aids in studying bone diseases and testing drugs without expensive bioprinting.
Area of Science:
- Biomaterials Engineering
- Tissue Engineering
- Musculoskeletal Biology
Background:
- Modeling musculoskeletal diseases like osteoporosis requires accurate in vitro human bone biology platforms.
- Conventional 3D culture systems are limited by high costs and specialized infrastructure.
Purpose of the Study:
- To develop a cost-effective and robust protocol for fabricating 3D bone constructs.
- To create an accessible platform for studying bone biology and disease progression.
Main Methods:
- Embedding human osteocytes in GelMA hydrogels supplemented with decellularized extracellular matrix (dECM) from human femoral heads.
- Utilizing a pipetting-based method at physiological temperature (37 °C) with standard laboratory equipment.
Main Results:
- Generated reproducible, bone-like 3D constructs with high cell viability and structural integrity.
- Demonstrated construct suitability for downstream applications like immunofluorescence and molecular assays.
- Incorporated patient-derived dECM to enhance translational relevance for bone remodeling studies.
Conclusions:
- The developed protocol offers a practical, scalable, and cost-effective alternative to high-cost bioprinting for 3D bone construct fabrication.
- This accessible platform supports drug testing, regenerative medicine, and mechanistic studies of bone biology.
- The method is adaptable to other tissue-specific dECM sources for broader applications.
